Friday 6 November 2026
Export NEPH’s income statement to Excel — free account
Nephros Inc.
NEPH Healthcare Medical Instruments & Supplies
Nephros Inc.’s revenue for fiscal 2025 (year ended December 2025) was $18.8 million, up 32.7% from fiscal 2024.
- Revenue
- +18.0%
- EPS
- +66.7%
- Free cash flow
- −251.5%
Quarter to September 2026, against a year earlier
2.83
0.26
−8.41%
Follow NEPH
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 From the 10-Q filed 5 Nov | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
7 | 3 | 4 | 4 |
| 12.71% | 7.76% | 16.10% | 16.95% | ||
| 9.61% | 6.07% | 12.39% | 13.39% | ||
ROIC |
14.92% | 6.33% | 14.11% | 14.29% | |
Return on Tangible Assets |
13.95% | 8.56% | 16.80% | 17.50% | |
Average Days of Receivables |
46.90 | 67.20 | 72.15 | 60.60 | |
Free Cash Flow per Share |
0.16 | (0.03) | (0.06) | (0.08) | |
Free Cash Flow |
1.65 | (0.35) | (0.66) | (0.91) | |
| Other line items | |||||
Cash ROIC |
10.54% | (2.36%) | (3.97%) | (5.32%) | |
Accounts Receivable Turnover |
8.96 | 6.17 | 6.75 | 6.91 | |
Accounts Payable Turnover |
9.17 | 7.58 | 6.18 | 9.53 | |
Inventory Turnover |
2.45 | 2.75 | 2.37 | 2.21 | |
Average Days of Payables |
46.57 | 69.71 | 89.35 | 36.44 | |
Days of Inventory on Hand |
164.67 | 172.45 | 206.76 | 212.34 | |
Tax Rate |
0.00 | 0.00 | (0.01) | 0.00 | |
Research and Development Expense of Revenue |
7.13% | 7.27% | 6.97% | 6.66% | |
Selling, General and Administrative Expense of Revenue |
47.90% | 48.46% | 45.77% | 44.86% | |
Share Based Compensation of Revenue |
1.58% | 1.46% | 1.30% | 1.20% | |
Interest Coverage |
— | — | 410.50 | — | |
Operating CF/Net income |
1.38 | (0.45) | (0.38) | (0.48) | |
Depreciation/Fixed assets |
1.31 | 1.33 | 1.46 | 1.61 | |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | 0.00 | |
Revenue per Share |
1.77 | 1.80 | 1.91 | 1.99 | |
Operating CF per Share |
0.16 | (0.03) | (0.06) | (0.08) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 |
Columns are period end dates · fundamentals updated 5 Nov 2026